Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMC 2679487)

Published in J Biol Chem on March 11, 2009

Authors

Marcela Popescu1, Zafer Gurel, Tapani Ronni, Chunhua Song, Ka Ying Hung, Kimberly J Payne, Sinisa Dovat

Author Affiliations

1: Department of Pediatrics, University of Wisconsin, Madison, Wisconsin 53792-4108, USA.

Articles citing this

The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci (2010) 2.51

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood (2015) 1.60

Sumoylation Inhibits the Growth Suppressive Properties of Ikaros. PLoS One (2016) 1.41

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proc Natl Acad Sci U S A (2012) 1.30

Ikaros, CK2 kinase, and the road to leukemia. Mol Cell Biochem (2011) 1.06

Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog (2011) 1.01

Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene. Pediatr Blood Cancer (2011) 0.92

Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res (2009) 0.89

Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1. World J Biol Chem (2011) 0.87

The IKAROS interaction with a complex including chromatin remodeling and transcription elongation activities is required for hematopoiesis. PLoS Genet (2014) 0.87

Regulator of myeloid differentiation and function: The secret life of Ikaros. World J Biol Chem (2011) 0.86

Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase. PLoS One (2013) 0.86

EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation. Proc Natl Acad Sci U S A (2013) 0.86

Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer (2011) 0.85

Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia. Oncotarget (2015) 0.84

Zinc finger structure-function in Ikaros Marvin A Payne. World J Biol Chem (2011) 0.84

Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia. Pediatr Blood Cancer (2014) 0.83

Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia. J Biol Chem (2015) 0.82

Ikaros in B cell development and function. World J Biol Chem (2011) 0.81

Vasoactive intestinal peptide signaling axis in human leukemia. World J Biol Chem (2011) 0.79

Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells. Cell Death Dis (2014) 0.78

Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site. J Biol Chem (2014) 0.77

Targeting CK2-driven non-oncogene addiction in B-cell tumors. Oncogene (2016) 0.77

KU HAPLOINSUFFIENCY CAUSES A LYMPHOPROLIFERATIVE DISORDER OF IMMATURE T-CELL PRECURSORS DUE TO IKAROS MALFUNCTION. Int J Mol Med Sci (2013) 0.77

Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis. PLoS One (2015) 0.77

Ikaros in hematopoiesis and leukemia. World J Biol Chem (2011) 0.77

Conserved residues in the N terminus of lipin-1 are required for binding to protein phosphatase-1c, nuclear translocation, and phosphatidate phosphatase activity. J Biol Chem (2014) 0.76

Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity. Eur J Immunol (2016) 0.75

Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer. PLoS One (2017) 0.75

Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia. Sci Rep (2016) 0.75

The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma. Genes Dev (2017) 0.75

High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement. Oncotarget (2016) 0.75

Articles cited by this

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68

Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (1986) 15.84

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 11.73

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12

PEST sequences and regulation by proteolysis. Trends Biochem Sci (1996) 8.90

Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell (1997) 5.62

Protein phosphatase 1--targeted in many directions. J Cell Sci (2002) 5.59

Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50

A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell (1995) 4.02

Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev (2004) 3.82

The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol (1994) 3.15

Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J (1999) 3.11

Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science (1996) 2.66

Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity (2007) 2.65

Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev (2000) 2.55

High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis. Blood (2002) 2.47

Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev (1998) 2.37

Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat Struct Biol (2003) 2.32

Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev (1998) 2.23

Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity (1999) 2.19

The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99

Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc Natl Acad Sci U S A (1998) 1.98

An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol (2000) 1.97

Differential subcellular localization of protein phosphatase-1 alpha, gamma1, and delta isoforms during both interphase and mitosis in mammalian cells. J Cell Biol (1998) 1.91

Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J Exp Med (1999) 1.82

Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem (2000) 1.81

Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med (1999) 1.76

Degeneracy and function of the ubiquitous RVXF motif that mediates binding to protein phosphatase-1. J Biol Chem (2003) 1.72

Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1999) 1.69

Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol (1999) 1.62

Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity (1997) 1.56

Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol (2004) 1.53

A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains. Genes Dev (2002) 1.53

Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. J Biol Chem (2006) 1.51

Ikaros SUMOylation: switching out of repression. Mol Cell Biol (2005) 1.48

A protein phosphatase-1-binding motif identified by the panning of a random peptide display library. J Biol Chem (1997) 1.40

Continuing rearrangement of immunoglobulin and T-cell receptor genes in a Ha-ras-transformed lymphoid progenitor cell line. Proc Natl Acad Sci U S A (1987) 1.37

Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas. J Immunol (1986) 1.34

Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase. Mol Cell Biol (2004) 1.34

Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem (2008) 1.29

Unconventional potentiation of gene expression by Ikaros. J Biol Chem (2002) 1.25

Interactor-mediated nuclear translocation and retention of protein phosphatase-1. J Biol Chem (2004) 1.25

Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev (2001) 1.24

Ikaros regulates neutrophil differentiation. Blood (2002) 1.23

In vitro maturation of clonal CD4+CD8+ cell lines in response to TCR engagement. J Immunol (1995) 1.16

Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res (2000) 1.12

Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem (2006) 1.06

Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res (1999) 1.03

Upstream of Ikaros. Trends Immunol (2003) 0.96

The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity. J Biol Chem (2002) 0.96

Trithorax interacts with type 1 serine/threonine protein phosphatase in Drosophila. EMBO Rep (2003) 0.93

Submicroscopic deletions in 5q- associated malignancies. Haematologica (2004) 0.92

Transcriptional control by chromosome-associated protein phosphatase-1. Biochem Soc Trans (2005) 0.82

Retracted IPP5, a novel protein inhibitor of protein phosphatase 1, promotes G1/S progression in a Thr-40-dependent manner. J Biol Chem (2008) 0.80

Articles by these authors

Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm (2010) 1.89

A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs. Nature (2008) 1.79

A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains. Genes Dev (2002) 1.53

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proc Natl Acad Sci U S A (2012) 1.30

Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem (2008) 1.29

IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol (2009) 1.28

Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing. Genome Res (2009) 1.22

Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood (2011) 1.12

Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization. Diabetes (2011) 1.11

Flightless I homolog negatively modulates the TLR pathway. J Immunol (2006) 1.11

Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am J Physiol Heart Circ Physiol (2006) 1.08

Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One (2013) 1.06

Ikaros, CK2 kinase, and the road to leukemia. Mol Cell Biochem (2011) 1.06

Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem (2006) 1.06

In vivo dual-tagging proteomic approach in studying signaling pathways in immune response. J Proteome Res (2005) 1.04

Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog (2011) 1.01

The LIM protein Ajuba regulates phosphatidylinositol 4,5-bisphosphate levels in migrating cells through an interaction with and activation of PIPKI alpha. Mol Cell Biol (2005) 1.01

Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther (2011) 1.00

Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells. Stem Cells (2007) 0.96

High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications. Biochem Biophys Res Commun (2013) 0.95

Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis. Am J Med Sci (2011) 0.95

XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep (2012) 0.92

Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene. Pediatr Blood Cancer (2011) 0.92

Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population. Medicine (Baltimore) (2016) 0.90

CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress. Am J Physiol Cell Physiol (2009) 0.89

Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res (2009) 0.89

The ubiquitin-like protein PLIC-1 or ubiquilin 1 inhibits TLR3-Trif signaling. PLoS One (2011) 0.88

Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome. Circ Cardiovasc Genet (2011) 0.88

Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1. World J Biol Chem (2011) 0.87

SCL expression at critical points in human hematopoietic lineage commitment. Stem Cells (2005) 0.87

Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor. Cell Res (2013) 0.86

Regulator of myeloid differentiation and function: The secret life of Ikaros. World J Biol Chem (2011) 0.86

Copper-mediated oxidative stress in rat liver. Biol Trace Elem Res (2003) 0.86

Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity. Am J Physiol Cell Physiol (2013) 0.86

Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis. Peptides (2011) 0.86

Ikaros isoforms: The saga continues. World J Biol Chem (2011) 0.85

Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer (2011) 0.85

Severe congenital protein C deficiency: description of a new mutation and prophylactic protein C therapy and in vivo pharmacokinetics. J Pediatr Hematol Oncol (2008) 0.84

The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long qt syndrome 9 (LQT9). J Biol Chem (2013) 0.84

Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia. Pediatr Blood Cancer (2014) 0.83

Genetic targets in pediatric acute lymphoblastic leukemia. Adv Exp Med Biol (2013) 0.82

Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro. Cancer Microenviron (2012) 0.82

Systematic evaluation of cancer risk associated with DNMT3B polymorphisms. J Cancer Res Clin Oncol (2014) 0.82

BIM deficiency differentially impacts the function of kidney endothelial and epithelial cells through modulation of their local microenvironment. Am J Physiol Renal Physiol (2011) 0.81

Induction of senescence by adenosine suppressing the growth of lung cancer cells. Biochem Biophys Res Commun (2013) 0.81

Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells. PLoS One (2013) 0.81

Association of single nucleotide polymorphisms in ERCC2 gene and their haplotypes with esophageal squamous cell carcinoma. Tumour Biol (2014) 0.80

Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. Cancer Epidemiol (2013) 0.80

Differences in mouse and human nonmemory B cell pools. J Immunol (2014) 0.80

Transposition of ISEcp1 modulates blaCTX-M-55-mediated Shigella flexneri resistance to cefalothin. Int J Antimicrob Agents (2013) 0.79

Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Mol Genet Genomics (2015) 0.79

Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros. J BUON (2014) 0.79

Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines. Neurobiol Aging (2008) 0.79

MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma. Mol Genet Genomics (2014) 0.78

Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. J Virol (2014) 0.78

Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy. Mol Vis (2012) 0.77

Casein kinase II (CK2) as a therapeutic target for hematological malignancies. Curr Pharm Des (2016) 0.76

Angiogenesis and survival in patients with myelodysplastic syndrome. Pathol Oncol Res (2012) 0.76

The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice. Curr Microbiol (2013) 0.76

AMID mediates adenosine-induced caspase-independent HuH-7 cell apoptosis. Cell Physiol Biochem (2011) 0.75

New universal primers for genotyping and resistance detection of low HBV DNA levels. Medicine (Baltimore) (2016) 0.75

HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility. Oncol Lett (2012) 0.75

Quality Control and Validation of Oscillometric Blood Pressure Measurements Taken During an Epidemiological Investigation. Medicine (Baltimore) (2015) 0.75

Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies. Medicine (Baltimore) (2016) 0.75

Coexistence of EZH2, NOTCH1, IL7R and PHF6 mutations in adult T cell acute lymphoblastic leukemia. Turk J Haematol (2017) 0.75

Novel functional variants locus in PLCE1 and susceptibility to digestive tract cancer in the Chinese population: a meta-analysis. Int J Biol Markers (2014) 0.75

[Influence of three primers on the shear bond strength between cast titanium and composite resin]. Hua Xi Kou Qiang Yi Xue Za Zhi (2014) 0.75

[Genetic polymorphisms of ADH1B and ALDH-2 associated with risk of esophageal cancer: a meta-analysis]. Wei Sheng Yan Jiu (2012) 0.75

Corrigendum: Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia. Sci Rep (2017) 0.75